about
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP aut...
Read More
2.14
-0.05
(-2.28%)
33,126
XNAS Volume
XNAS 31 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
BioCardia Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..